Combining the oncolytic peptide LTX-315 with doxorubicin demonstrates therapeutic potential in a triple-negative breast cancer model

Ketil André Camilio(Oslo University Hospital), Gunhild M. Mælandsmo(Oslo University Hospital)
Breast Cancer Research
January 22, 2019
Cited by 65


Related Papers